Omeros suspends its Huntington's clinical trial
Omeros announced it has suspended its Huntington's clinical trial as it further evaluates an observation from a nonclinical study in rats. The observation occurred in several of the rats receiving the study's maximum dose of OMS824. October 21, 2014